{"retracted":false,"update":{"timestamp":1448928000000,"doi":"10.1016/j.berh.2015.10.002","type":"err"},"doi":"10.1016/j.berh.2015.05.009","journal":"Best Practice & Research Clinical Rheumatology","publisher":"Elsevier BV","title":"Corrigendum to “Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis” [Best Pract Res Clin Rheumatol 29 (2) (2015) 290–305]"}
